A few years ago, the drug companies dominating mergers-and-acquisitions headlines were largely household names, from Pfizer Inc. and Merck & Co. to Novartis AG.
These days, a new generation of deal makers is making news, with names distinctly less familiar: Actavis PLC, Endo International PLC and Valeant Pharmaceuticals International Inc. Within the past few weeks, two other relatively under-the-radar companies, Mylan NV and Teva Pharmaceutical Industries Ltd. , also entered the fray.
Hey, check out all the research scientist jobs. Post your resume today!
